Bibliografia UJ CM




Zapytanie: FULLER J H
Liczba odnalezionych rekordów: 12



Przejście do opcji zmiany formatu | Wyświetl/ukryj etykiety | Wersja do druku | | | Nowe wyszukiwanie
1/12
B.C.T. van Bussel, S.S. Soedamah-Muthu, R.M.A. Henry, C.G. Schalkwijk, I. Ferreira, N. Chaturvedi, M. Toeller, J.H. Fuller, C.D.A. Stehouwer, EURODIAB Prospective Complications Study Group.
Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: The EURODIAB study.
NMCD, Nutr. Metab. Cardiovasc. Dis. (Testo stamp.)
2013 : Vol. 23, nr 8, s. 758-764, il., bibliogr. 30 poz., abstr.
p-ISSN: 0939-4753

AZ
ORG
AIF
IF: 3.875
Adres url:
Streszczenie w PubMed:
2/12
D.A.J.M. Schoenaker, M. Toeller, N. Chaturvedi, J.H. Fuller, S.S. Soedamah-Muthu, EURODIAB Prospective Complications Study Group.
Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study.
Diabetologia
2012 : Vol. 55, nr 8, s. 2132-2141, bibliogr. 50 poz., abstr.
p-ISSN: 0012-186X

AZ
ORG
AIF
IF: 6.487
Adres url:
Streszczenie w PubMed:
3/12
M. Porta, J.W. Hainer, S.-O. Jansson, R. Bilous, N. Chaturvedi, J.H. Fuller, R. Klein, T. Orchard, H.-H. Parving, A.-K. Sjolie, DIRECT Study Group.
Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes
( : experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.)
Diabetologia
2011 : Vol. 54, nr 6, s. 1298-1030, il., bibliogr. 14 poz., abstr.
p-ISSN: 0012-186X

AZ
ORG
AIF
IF: 6.814
4/12
J.B. Ferriss, D. Webb, N. Chaturwedi, J.H. Fuller, B[arbara] Idzior-Walus, EURODIAB Prospective Complications Group.
Weight gain is associated with improved glycaemic control but within adverse changes in plasma lipids and blood pressure in Type 1 diabetes.
Diabetic Medicine
2006 : Vol. 23, nr 5, s. 557-564, bibliogr. 29 poz., abstr.
AZ
ORG
AIF
IF: 2.484
Adres url:
5/12
S.S. Soedamah-Muthu, N. Chaturvedi, T. Teerlink, B[arbara] Idzior-Walus, J.H. Fuller, C.D.A. Stehouwer, The EURODIAB Prospective Complications Study Group.
Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes : a cross-sectional nested case-control study.
Journal of Internal Medicine
2005 : Vol. 258, nr 5, s. 450-459, bibliogr. 50 poz., abstr.
AZ
ORG
AIF
IF: 4.040
Adres url:
6/12
B[arbara] Idzior-Walus, M.B. Mattock, B[ogdan] Solnica, L. Stevens, J.H. Fuller, The EURODIAB IDDM Complications Study Group.
Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus : the EURODIAB IDDM Complications Study.
Diabetic Medicine
2001 : Vol. 18, s. 786-796, bibliogr.
AZ
ORG
AIF
IF: 2.678
7/12
M.B. Mattock, N. Cronin, P. Cavallo-Perin, B[arbara] Idzior-Walus, G. Penno, S. Bandinelli, E. Standl, A. Kofinis, J.H. Fuller, The EURODIAB IDDM Complications Study Group.
Plasma lipids and urinary albumin excretion rate in type 1 diabetes mellitus : the EURODIAB IDDM Complications Study.
Diabetic Medicine
2001 : Vol. 18, s. 59-67, bibliogr. 43 poz., abstr.
AZ
ORG
AIF
IF: 2.678
8/12
A.E. Buyken, M. Toeller, G. Heitkamp, K. Irsigler, C. Holler, F. Santeusanio, P. Stehle, J.H. Fuller, Complications Study Group EURODIAB IDDM.
Carbohydrate sources and glycaemic control in Type 1 diabetes mellitus.
Diabetic Medicine
2000 : Vol. 17, nr 5, s. 351-359, il., bibliogr. 33 poz., abstr.
AZ
ORG
AIF
IF: 2.732
Adres url:
9/12
B[arbara] Idzior-Waluś, L. Stevens, J[acek] Sieradzki, J.H. Fuller.
Serum lipid values and central obesity in type 1 diabetes - the EURODIAB IDDM Complications Study. (Wartości lipidów w surowicy i otyłość brzuszna w cukrzycy typu 1).
Diabetologia
1999 : Vol. 42 suppl. 1 s. A 285, abstr. 1079.
35th Annual Meeting of the EASD, Brussels, Belgium, 28 September-2 October 1999.
SZZ
SIF
10/12
B[arbara] Idzior-Waluś, J[acek] Sieradzki, L. Stevens, J.H. Fuller.
Związek pomiędzy paleniem papierosów i stężeniem lipidów w surowicy u pacjentów z cukrzycą typu 1, objętych badaniem EURODIAB IDDM Complications Study.
(The relationship between smoking and serum lipids in type 1 diabetics included in the EURODIAB IDDM Complications Study.)
Diabetologia Polska
1999 : Vol. 6 supl. 1, s. S44, abstr. U 48
VII Zjazd Naukowy Polskiego Towarzystwa Diabetologicznego, Wrocław, 27-30 maja 1999.
SZP
AWZ
11/12
M. Greaves, R.G. Malia, K. Goodfellow, M. Mattock, L.K. Stevens, J.M. Stephenson, J.H. Fuller, Complications Study Group EURODIAB IDDM.
Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate : the EURODIAB IDDM Complications Study.
Diabetologia
1997 : Vol. 40, nr 6, s. 698-705, il., bibliogr, 56 pos., summ.
AZ
ORG
AIF
IF: 5.347
12/12
N. Chaturvedi, J.M. Stephenson, J.H. Fuller, The EURODIAB IDDM Complications Study Group.
The relationship between pregnancy and long-term maternal complications in the EURODIAB IDDM complications study.
Diabetic Medicine
1995 : Vol. 12, nr 6, s. 494-499
p-ISSN: 0742-3071
e-ISSN: 1464-5491

AZ
ORG
AIF
IF: 1.353
  Wyświetl ponownie stosując format:
Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ